THE ULTIMATE ONE WOMEN TRISORB
Natural health product licensed in Canada
- Licence holder
- Lifeagen Biosciences of Florida, Inc. dba Nu-Life North America
- NPN or DIN-HM
- 80042906
- Status
- Active licence
- Licence date
- 17 June 2013
- Revision date
- Not provided
- Form
- Caplet
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Thiamine Source : Mononitrate de thiamine | 35 mg | Not calculated |
| Calcium Source : Citrate de calcium | 10 mg | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 100 mcg | Not calculated |
| Niacinamide Source : Nicotinamide | 30 mg | Not calculated |
| Potassium Source : Citrate de potassium | 35 mg | Not calculated |
| Camellia sinensis Source : Extrait de Feuille Extraction ratio : 35:1 Dry plant equivalent : 700 mg | 20 mg | Not calculated |
| Iode Source : Kelp thallus | 500 mcg | Not calculated |
| Reynoutria japonica Source : Root extract (standardised) Potency : 50 % resveratrol | 5 mg | Not calculated |
| Calcium Source : Carbonate de calcium | 115 mg | Not calculated |
| Ginkgo biloba Source : leaf standardized extract Potency : 6 % terpene lactones | Not specified | Not calculated |
| Ginkgo biloba Source : leaf standardized extract Extraction ratio : 50:1 Dry plant equivalent : 500 mg Potency : 24 % flavone glycosides | 10 mg | Not calculated |
| Riboflavine Source : Riboflavine | 40 mg | Not calculated |
| Riboflavine Source : Riboflavine-5-phosphate | 40 mg | Not calculated |
| Vitamine B6 Source : Pyridoxine HCl Pyridoxal-5-Phosphate | 35 mg | Not calculated |
| Manganèse Source : Manganous citrate | 4 mg | Not calculated |
| Acide L-alpha-acétamido-bêta-mercaptopropionique Source : L-alpha-Acetamido-beta-mercaptopropionic acid | 5 mg | Not calculated |
| (Carboxymethyl)trimethylammonium chloride Source : Chlorhydrate de bétaine | 30 mg | Not calculated |
| Molybdène Source : Molybdate de sodium | 50 mcg | Not calculated |
| Acide 4-aminobenzoïque Source : 4-aminobenzoic acid | 25 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Lécithine, Dioxyde de silicium, Croscarmellose de sodium, Acide stéarique, Carboxyméthylcellulose, Vanille (de Tahiti), citrate de sodium, Dextrine, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Caplet | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps the body to metabolize carbohydrates, fats and proteins. Helps to form red blood cells. Helps normal growth and development. Helps in tissue formation. Helps normal growth. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in wound healing. An antioxidant for the maintenance of good health. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Provides support for healthy glucose metabolism. Helps to produce and repair connective tissue. Helps in the function of the thyroid gland. Helps to form red blood cells and helps in their proper function. Helps to maintain proper muscle function. Helps to maintain immune function. Helps to maintain healthy skin. Source of vitamin A for the maintenance of good health. Source of vitamin A to help maintain eyesight, skin, membranes and immune function. Source of vitamin A to help in the development and maintenance of night vision. Source of vitamin A to help in the development and maintenance of bones and teeth. Digestive enzyme. An antioxidant.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80042906
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.